Immuron (IMRN) EPS (Basic) Growth (3y) (2019 - 2024)
Immuron (IMRN) EPS (Basic) Growth (3y) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.76 Bn | 130.91 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 86.15 Bn | 78.15 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 64.45 Bn | 59.27 Bn | 1.37 Bn | 64.84% |
| 4 | Moderna | 57.08 Bn | 51.94 Bn | 52.00 Mn | 18.44% |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn | 37.21% |
| 6 | Alnylam Pharmaceuticals | 30.90 Bn | 27.59 Bn | 992.69 Mn | 36.73% |
| 7 | BioNTech SE | 27.76 Bn | 9.37 Bn | 668.28 Mn | -26.87% |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 67.51% |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - | -38.31% |
| 10 | Immuron | 6.75 Mn | 6.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -391.98% |
| Dec 31, 2023 | -203.56% |
| Dec 31, 2022 | -161.35% |
| Dec 31, 2021 | 82.71% |
| Dec 31, 2020 | 71.27% |
| Dec 31, 2019 | 86.34% |